Almirall - Aktuellt https://www.mynewsdesk.com/se/almirall Mynewsdesk RSS - pressmeddelanden, nyheter och blogginlägg. Almirall - Aktuellt https://www.mynewsdesk.com/se/almirall https://www.mynewsdesk.com/assets/graphics/logos/logo-small-9892f98564f91864075bd14001f8470f2f9bf254729c37044b4b1ac9b0db6b40.png 128 23 sv 15 Almirall är Diamant-sponsor under NCDV, Nordic Congress of Dermatology and Venereology, den 7-9 maj 2025 i Helsingfors Wed, 07 May 2025 08:00:00 +0200 Almirall är Diamont-sponsor på NCDV i Helsingfors 7-9 maj 2025! https://www.mynewsdesk.com/se/almirall/news/almirall-aer-diamant-sponsor-under-ncdv-nordic-congress-of-dermatology-and-venereology-den-7-9-maj-2025-i-helsingfors-497000?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/almirall/news/almirall-aer-diamant-sponsor-under-ncdv-nordic-congress-of-dermatology-and-venereology-den-7-9-maj-2025-i-helsingfors-497000?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Almirall AB Almirall firar internationella psoriasisdagen den 29 oktober 2024 Tue, 29 Oct 2024 16:16:25 +0100 Årets kampanj från Almirall under internationella psoriasisdagen heter "Me & My Inner Circle". https://www.mynewsdesk.com/se/almirall/news/almirall-firar-internationella-psoriasisdagen-den-29-oktober-2024-489864?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/almirall/news/almirall-firar-internationella-psoriasisdagen-den-29-oktober-2024-489864?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Almirall AB Almirall initiates first phase I clinical study of ALM223, an interleukin 2 mutant fusion protein for autoimmune diseases Thu, 21 Dec 2023 00:00:00 +0100 https://www.mynewsdesk.com/se/almirall/pressreleases/almirall-initiates-first-phase-i-clinical-study-of-alm223-an-interleukin-2-mutant-fusion-protein-for-autoimmune-diseases-3299727?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/almirall/pressreleases/almirall-initiates-first-phase-i-clinical-study-of-alm223-an-interleukin-2-mutant-fusion-protein-for-autoimmune-diseases-3299727?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Almirall AB Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology Tue, 12 Dec 2023 00:00:00 +0100 https://www.mynewsdesk.com/se/almirall/pressreleases/almirall-and-etherna-enter-into-a-multi-target-alliance-to-develop-mrna-based-therapies-in-medical-dermatology-3299723?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/almirall/pressreleases/almirall-and-etherna-enter-into-a-multi-target-alliance-to-develop-mrna-based-therapies-in-medical-dermatology-3299723?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Almirall AB Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases Tue, 14 Nov 2023 00:00:00 +0100 https://www.mynewsdesk.com/se/almirall/pressreleases/almirall-and-absci-announce-ai-drug-discovery-partnership-to-rapidly-develop-novel-treatments-for-dermatological-diseases-3299718?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news https://www.mynewsdesk.com/se/almirall/pressreleases/almirall-and-absci-announce-ai-drug-discovery-partnership-to-rapidly-develop-novel-treatments-for-dermatological-diseases-3299718?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=current_news Almirall AB